Badlon, Gabriel .
HRN: 24-26-01 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/10/2025
CEFTRIAXONE 1G (VIAL)
04/10/2025
04/17/2025
IV
2G
Q24
MULTIPLE ABRASIONS SEC TO MVA
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes